Experience the Molbio advantage

Molbio Diagnostics is a pioneering Indian in-vitro diagnostics (IVD) company with a global footprint. We have deep expertise in development, production, and commercialization of pathbreaking diagnostic platforms that address the clinical need gaps and are deployed at Point-of-Care (POC), resource-limited settings. Our flagship product, Truenat, has been successfully deployed across 85+ countries and has positively impacted millions of lives. Bigtec Labs is the R&D division of Molbio and functions as an innovation engine with a multidisciplinary team of 100 scientists and engineers, who excel in translating scientific ideas into market-ready products.

About EDGE 2.0

Following the successful completion of EDGE 2024, Molbio and Bigtec now bring EDGE 2.0, a pioneering scaleup partnership program for MedTech startups, for acceleration of product development and commercialization. Molbio and Bigtec are launching a global call to collaborate with MedTech startups and SMEs for acceleration of product development and commercialization. This is an intensive 12-week cohort program for understanding high impact technology acceleration and faster Go-To-Market (GTM) traction. At the end of this program, Molbio would engage with a few cohort participants for future partnerships. This would potentially involve bridge funding for product co-development, licensing, sales and distribution. Each cohort participant will receive bespoke guidance. The program will be conducted in hybrid mode and will involve intermittent visits to Bangalore and Goa. All expenses, including travel and stay, of the program will be borne by Molbio.

Call Areas

The second EDGE call is open in the areas of Point-of-Care (POC), ideally rapid, or Near Care Devices or Critical Technology Elements (CTEs) which can be used for human diagnostics -and are in early stages of development (TRL 2 to TRL 6). These may include the following, but not limited to:

1

Novel concepts that address diagnosis of infectious diseases and Non-Communicable Diseases (NCDs)

2

Novel concepts in genetic testing, such as SNP detection approaches using isothermal amplification methods

3

Antimicrobial Resistance (AMR) detection including genotypic and rapid phenotypic Antimicrobial Susceptibility Test (AST)

Program Value

Leverage the expertise of Molbio and Bigtec to cross the ‘valleys of death’

Masterclass and Workshops

With global leaders in public health and MedTech industry in areas of innovation, strategy, regulatory, GTM, and sales

R&D and Manufacturing

Technical expertise and rapid MVP to production through best-in-class DFM

Validation and Regulatory

Well-established global ecosystem of validation partners and regulatory expertise

Partnership Opportunity

Access to Centre of Excellence (CoE) and potential funding opportunities for transition to scale

Sales

Connecting with our expansive distribution network in 85+ countries

Visits

In-person workshops at Bigtec, Bangalore, and production sites at Molbio, Goa